1Life Healthcare Inc. (NASDAQ:ONEM) does about 1.87M shares in volume on a normal day but saw 3436397 shares change hands in Tuesday trading. The company now has a market cap of 3.82B USD. Its current market price is $30.23, marking an increase of 3.63% compared to the previous close of $29.17. The 52 week high reached by this stock is $44.87 whilst the lowest price level in 52 weeks is $15.00. The script in recent trading has seen the stock touch a high of $30.35 and a low of $29.13.
1Life Healthcare Inc. (ONEM) has a 20-day trading average at $29.31 and the current price is -32.63% off the 52-week high compared with 101.53% distance from its 52-week low. The 50-day simple moving average of the closing price is $33.12. If we look at the stock’s price movements over the week, volatility stands at 3.18%, which increases to 4.95% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 48.17 to suggest the stock is neutral.
10 analysts observing the 1Life Healthcare Inc. (ONEM) stock have set the 12-month price targets for the company’s shares at between $28.00 and $43.00. The consensus objective for the share price is $36.11, suggesting that the stock has a potential upside of 16.28% over the period. The median price target is 16.03% away from the current levels at $36.00.
FactSet Research has provided data showing that 10 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 6 analysts have rated it as a buy and 4 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 01, 2020 when SVB Leerink initiated the stock to “Mkt Perform” and issued a price target of $36.
The current price level is 3.12%, -8.96%, and 8.49% away from its SMA20, SMA50, and SMA200 respectively, with the ONEM price moving above the 50-day SMA on September 01. 1Life Healthcare Inc. (ONEM) stock is up 6.82% over the week and 0.73% over the past month. Its price is 36.97% year-to-date.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.24 above consensus estimates by $0.09. The company’s next earnings report is expected on 11/12/2020, with forecasts estimating quarterly EPS at -$0.18 and -$0.95 for whole year. ONEM’s earnings per share are forecast to grow by 66.50% this year and 36.80% over next year. Expected sales for next quarter are $90.22 million, which analysts say will come at $333.41 million for the current fiscal year and next year at $433.45 million. In addition, estimates put the company’s current quarterly revenue at an average of $86.31 million.
Its 12-month price target is $36.00. To reach the target analysts have set, the stock logically needs to grow 16.28 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $28.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $43.00.
Outstanding shares total 126.15M with insiders holding 9.81% of the shares and institutional holders owning 67.36% of the company’s common stock. The company has a return on investment of 29.50% and return on equity of -63.40%. Price to book ratio is 7.36 and price to sales ratio is 12.67.
According to a U.S. Securities and Exchange Commission filing, BNY Mellon Small/Mid Cap Growth F has added its position in 1Life Healthcare Inc. (ONEM) to 1,476,424 shares, mirroring a recent increase by 3.80%. BNY Mellon Small/Mid Cap Growth F added 54089.0 shares of 1Life Healthcare Inc. common stock bringing its total worth to about $43.72 million at the end of recent close, SEC documents show. BNY Mellon Small/Mid Cap Growth F isn’t the only investment manager who changed stakes and is followed by Fidelity Advisor Series I -Growth, which added 0.1 million shares to end up with 1,166,363 shares worth $34.54 million. Fidelity Global Innovators Invest raise their holdings by 33.91% in the company over the course of the most recent quarter. It now holds a 0.86% position in 1Life Healthcare Inc. thanks to 1.08 million shares amounting to $32.08 million.